MCC
TGTX icon

Money Concepts Capital’s TG Therapeutics TGTX Stock Holding History

Money Concepts Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-124
Closed -$1.47K – 2651
2022
Q4 		$1.47K Hold
124
– – ﹤0.01% 2791
2022
Q3 		$1K Buy
+124
New +$813 ﹤0.01% 1511
2022
Q2 		– Sell
-151
Closed -$1K – 2516
2022
Q1 		$1K Buy
+151
New +$1.75K ﹤0.01% 2606

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Money Concepts Capital's TGTX Position: Q1 2023 in Review

Money Concepts Capital sold out of TG Therapeutics (TGTX) in Q1 2023, closing a stake of 124 shares — an estimated $1.47K sold.

Money Concepts Capital first reported a position in TGTX in Q1 2022 and held it in 3 quarters. The position peaked at $1.47K in Q4 2022. 214 funds tracked by Wall St. Rank hold TGTX as of Q1 2023.

  • Money Concepts Capital reported no remaining TG Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 124 TG Therapeutics shares in Q1 2023, an estimated $1.47K.
  • Money Concepts Capital first reported a position in TG Therapeutics in Q1 2022 and held it in 3 quarters.
  • Money Concepts Capital's TG Therapeutics position peaked at $1.47K in Q4 2022.
  • 214 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.